Pulmonary mycobacterial spindle cell pseudotumor in a lung transplant patient: progression without therapy and response to therapy

Transpl Infect Dis. 2015 Jun;17(3):424-8. doi: 10.1111/tid.12390. Epub 2015 Jun 1.

Abstract

Mycobacterial spindle cell pseudotumor (MSP) represents a rare, non-malignant, mass-forming reaction to various mycobacterial infections, typically occurring in immunocompromised patients. It is characterized by the proliferation of spindle-shaped fibrohistiocytic cells without the formation of epithelioid granulomas. Without staining for acid-fast bacilli, histological distinction from other spindle cell lesions, including malignancy, can be difficult. Most of the MSP cases reported in the literature have involved lymph nodes, skin, spleen, or bone marrow, but rarely involve the lung. MSP predominately occurs in patients who are immunosuppressed. We present a patient with MSP of the transplanted lung caused by non-tuberculous mycobacteria, in whom both the natural course of the untreated pseudotumor as well as the response to antimycobacterial treatments were observed.

Keywords: Mycobacterium avium complex; lung transplant; mycobacterial spindle cell pseudotumor; non-tuberculous mycobacteria.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage*
  • Azithromycin / administration & dosage
  • Disease Progression
  • Ethambutol / administration & dosage
  • Female
  • Fluoroquinolones / administration & dosage
  • Humans
  • Immunocompromised Host
  • Lung / diagnostic imaging
  • Lung / surgery
  • Lung Transplantation*
  • Moxifloxacin
  • Mycobacterium avium Complex / isolation & purification*
  • Mycobacterium avium-intracellulare Infection / diagnostic imaging
  • Mycobacterium avium-intracellulare Infection / drug therapy
  • Mycobacterium avium-intracellulare Infection / microbiology*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Azithromycin
  • Ethambutol
  • Moxifloxacin